| Product Code: ETC7733478 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
In 2024, Japan continued to import budesonide inhalers mainly from top exporting countries such as Germany, Switzerland, USA, Italy, and Metropolitan France. Despite the low concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for the period 2020-2024 saw a decline of -5.32%. Furthermore, the growth rate from 2023 to 2024 also experienced a decrease of -3.46%. These figures suggest a stable market with a consistent flow of imports, albeit at a slightly declining rate.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Budesonide Inhaler Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Budesonide Inhaler Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Budesonide Inhaler Market - Industry Life Cycle |
3.4 Japan Budesonide Inhaler Market - Porter's Five Forces |
3.5 Japan Budesonide Inhaler Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Budesonide Inhaler Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 Japan Budesonide Inhaler Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.8 Japan Budesonide Inhaler Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Japan Budesonide Inhaler Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Budesonide Inhaler Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases in Japan. |
4.2.2 Growing awareness about the benefits of using budesonide inhalers for asthma and COPD management. |
4.2.3 Technological advancements leading to the development of more effective and user-friendly inhaler devices. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and marketing of inhaler products in Japan. |
4.3.2 Competition from alternative treatment options such as oral medications or nebulizers. |
4.3.3 Price sensitivity among consumers due to the availability of generic alternatives. |
5 Japan Budesonide Inhaler Market Trends |
6 Japan Budesonide Inhaler Market, By Types |
6.1 Japan Budesonide Inhaler Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Budesonide Inhaler Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Japan Budesonide Inhaler Market Revenues & Volume, By Nebulizer, 2021- 2031F |
6.1.4 Japan Budesonide Inhaler Market Revenues & Volume, By Inhalants, 2021- 2031F |
6.2 Japan Budesonide Inhaler Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 Japan Budesonide Inhaler Market Revenues & Volume, By Dry Powder, 2021- 2031F |
6.2.3 Japan Budesonide Inhaler Market Revenues & Volume, By Spray, 2021- 2031F |
6.2.4 Japan Budesonide Inhaler Market Revenues & Volume, By Suspension, 2021- 2031F |
6.2.5 Japan Budesonide Inhaler Market Revenues & Volume, By Aerosols, 2021- 2031F |
6.3 Japan Budesonide Inhaler Market, By Strength |
6.3.1 Overview and Analysis |
6.3.2 Japan Budesonide Inhaler Market Revenues & Volume, By 0.25mg, 2021- 2031F |
6.3.3 Japan Budesonide Inhaler Market Revenues & Volume, By 0.5mg, 2021- 2031F |
6.3.4 Japan Budesonide Inhaler Market Revenues & Volume, By 1.0mg, 2021- 2031F |
6.4 Japan Budesonide Inhaler Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Japan Budesonide Inhaler Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Japan Budesonide Inhaler Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5 Japan Budesonide Inhaler Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Budesonide Inhaler Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Japan Budesonide Inhaler Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Japan Budesonide Inhaler Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Japan Budesonide Inhaler Market Import-Export Trade Statistics |
7.1 Japan Budesonide Inhaler Market Export to Major Countries |
7.2 Japan Budesonide Inhaler Market Imports from Major Countries |
8 Japan Budesonide Inhaler Market Key Performance Indicators |
8.1 Patient adherence rate to budesonide inhaler therapy. |
8.2 Number of healthcare professionals prescribing budesonide inhalers. |
8.3 Rate of new product launches and innovations in the budesonide inhaler market. |
8.4 Patient satisfaction and reported improvements in symptoms after using budesonide inhalers. |
8.5 Frequency of educational campaigns and awareness programs about budesonide inhalers among healthcare providers and patients. |
9 Japan Budesonide Inhaler Market - Opportunity Assessment |
9.1 Japan Budesonide Inhaler Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Budesonide Inhaler Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.3 Japan Budesonide Inhaler Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.4 Japan Budesonide Inhaler Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Japan Budesonide Inhaler Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Budesonide Inhaler Market - Competitive Landscape |
10.1 Japan Budesonide Inhaler Market Revenue Share, By Companies, 2024 |
10.2 Japan Budesonide Inhaler Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |